Skip to main content

Table 2 Procedure Characteristics by Treatment Catheters and Outcomes

From: Rheolytic thrombectomy using an AngioJet ZelanteDVT catheter or a Solent Omni catheter for patients with proximal vein thrombosis

Characteristics

ZelanteDVT Group (n = 17)

Solent Group (n = 23)

p value

Success of thrombus removal, n (%)

 Primary RT success

12 (70.6)

6 (26.1)

.010

 Adjuvant CDT success

5 (29.4)

16 (69.6)

.018

Clinical success

17 (100)

22 (95.7)

1.000

Adjuvant other endovascular methods, n (%)

 Balloon angioplasty

11 (64.7)

13 (56.5)

.747

 Stent placement

6 (35.3)

4 (17.4)

.274

Duration of operation procedure, (h, mean ± SD)

1.61 ± .15

1.72 ± .22

.086

RT procedure

 Patients used PP model, n (%)

14 (82.4)

20 (87.0)

1.000

 Mean RT duration time, (s, mean ± SD)

47.65 ± 14.37

73.91 ± 18.52

.000

Adjuvant CDT procedure

 Number, n (%)

5 (29.4)

17 (73.9)

.010

 Mean duration time, d

2.00 ± 1.22

3.00 ± 1.27

.136

 rt-PA dose, mg

18.20 ± 11.10

27.35 ± 12.19

.149

Thrombus scores

 Pre-RT

9.65 ± 2.15

9.57 ± 1.90

.899

 RT-completion

2.71 ± 2.64

4.35 ± 2.31

.043

 CDT-completion

2.00 ± 1.40

1.65 ± 1.46

.637

Thrombus removal grades, n (%)

 Grade I

0 (0)

1 (4.3)

1.000

 Grade II

10 (58.8)

13 (56.5)

1.000

 Grade III

7 (41.2)

9 (39.1)

1.000

Complications, n (%)

 Minor (SIR A, B: nominal or no therapy, no consequence)

1 (5.9)

5 (21.7)

.216

 Major (SIR C, D, E: requires therapy or permanent sequelae)

0 (0)

0 (0)

 Major-death (SIR F: death)

0 (0)

0 (0)

Procedure-related PE, n (%)

0 (0)

0 (0)

In-hospital length of stay, d

7.99 ± 2.09

9.91 ± 3.00

.030

PTS at 6-month follow-up, n (%)

1 (5.9)

4 (17.4)

.546

  1. DVT Deep vein thrombosis, CDT Catheter-directed thrombolysis, RT Rheolytic thrombectomy, PP Power pulse
  2. Continuous data are presented as the means ± standard deviations; categorical data are given as the counts (percentages)